within Pharmacolibrary.Drugs.ATC.J;

model J01CF01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00014333333333333334,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.015500000000000002,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CF01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dicloxacillin is a narrow-spectrum beta-lactam antibiotic of the penicillin class, used primarily to treat infections caused by penicillinase-producing staphylococci. It is active against Gram-positive bacteria and is approved for clinical use in many countries for conditions such as skin and soft tissue infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral dosing.</p><h4>References</h4><ol><li><p>Bock, M, et al., &amp; Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 77(2) 242–251. DOI:<a href=&quot;https://doi.org/10.1093/cid/ciad168&quot;>10.1093/cid/ciad168</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36947131/&quot;>https://pubmed.ncbi.nlm.nih.gov/36947131</a></p></li><li><p>Wu, G, et al., &amp; Shentu, J (2015). Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses. <i>Drug design, development and therapy</i> 9 5687–5695. DOI:<a href=&quot;https://doi.org/10.2147/DDDT.S92117&quot;>10.2147/DDDT.S92117</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26527863/&quot;>https://pubmed.ncbi.nlm.nih.gov/26527863</a></p></li><li><p>Røder, BL, et al., &amp; Rasmussen, SN (1995). Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. <i>Infection</i> 23(2) 107–112. DOI:<a href=&quot;https://doi.org/10.1007/BF01833876&quot;>10.1007/BF01833876</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7622258/&quot;>https://pubmed.ncbi.nlm.nih.gov/7622258</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CF01;
